By Daniels Porco & Lusardi, LLP | Published June 29, 2018 | Posted in Health Care Law | Tagged Tags: Health Care Law | Comments Off on Chairman Of Key Congressional Health Committee Talks Reform
Rep. Peter J. Roskam (R-IL) is clearly adamant about taking some action that he stresses is imperative to safeguard the health care industry against crushing regulatory challenges of the highest order. Here’s the problem, Roskam asserts: Health professionals are flailing under an onslaught – relentless and growing – of burdensome and often nonsensical regulation. The Read More
Read MoreWhen a judge allows highly prejudicial and case-irrelevant evidence to be “wafted before the jury to trigger its punitive instincts,” it is likely that an appellate tribunal will take action. Which is exactly what a federal appeals panel did last week in New Orleans. Appellate judges cited a lower court’s error in allowing plaintiffs’ counsel Read More
Read MoreA recent in-depth media profile calls it “a target-rich environment for investigation and prosecution.” That same report also stresses that federal criminal enforcement over it “stands poised to become increasingly muscular and robust.” The subject matter comprising “it” in the above piece is health care fraud. That realm is unquestionably a top-tier focus of national Read More
Read MorePatient safety is, or should be, a top priority in every health care facility in New York and the rest of the country. Safety can be at risk many different ways. One major threat that deserves particular attention is that posed by cyber attackers going after network-linked equipment and medical data. To show just how significant Read More
Read MoreMuch criticism of the U.S. Food and Drug Administration from health care analysts and commentators spotlights alleged overregulation of the medical realm and its adverse effects on both business growth and innovation. That has once again proven to be true in the response of one industry group to recent FDA-authored draft guidance concerning software that Read More
Read MoreThe process applicable to formal rulemaking engaged in by federal agencies is lengthy and laborious. A recent Bloomberg article discussing how ideas turn into final administrative rules describes it as “cumbersome.” No one likely knows that better than principal employees of the U.S. Food and Drug Administration. The FDA is an agency that is routinely Read More
Read MoreGiven the bottom line linked with human lives and patient safety, it is hardly surprising that the health care realm is one of the most tightly regulated industries in the world. In the United States, of course, it is the U.S. Food and Drug Administration that plays an especially close and exacting rule in ensuring Read More
Read MoreConscientious health care providers across New York — doctors, nurses, pharmacists, lab technicians and others — routinely think about care quality and how to best ensure that their patients are receiving it. While doing so, though, they are also focused on an additional matter these days that has nothing to do with patient outcomes and Read More
Read MoreHealth care “is complicated,” stresses a recent New York Times article. And, notes that piece, a potential new industry player might soon be coming to grips with just how utterly complex the hoops and hurdles relevant to that huge chunk of the economy can be. Notwithstanding the regulatory exactions — authored by local, state and Read More
Read MoreA recent study has shown that several states have expanded or enhanced their Medicaid benefits this year, with several planning to do so next year. The increased benefits were primarily for mental health treatment and substance abuse. Some of the other treatments that saw expanded benefits include telemedicine, dental care, oral contraceptives, and cancer screenings. Read More
Read More